Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021

Tofacitinib for the treatment of ankylosing spondylitis: a phase III, randomised, double-blind, placebo-controlled study

(2021) Atul Deodhar et al.   ANNALS OF THE RHEUMATIC DISEASES

Trial of Upadacitinib and Adalimumab for Psoriatic Arthritis

(2021) Iain B. McInnes et al.   NEW ENGLAND JOURNAL OF MEDICINE

Biological disease-modifying antirheumatic drugs may mitigate the risk of psoriatic arthritis in patients with chronic plaque psoriasis

(2021) Paolo Gisondi et al.   ANNALS OF THE RHEUMATIC DISEASES

AB0559 EFFICACY AND SAFETY OF RISANKIZUMAB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS AFTER INADEQUATE RESPONSE OR INTOLERANCE TO DMARDs: 24-WEEK RESULTS FROM THE PHASE 3, RANDOMIZED, DOUBLE-BLIND KEEPsAKE 1 TRIAL

(2021) L. E. Kristensen et al.   ANNALS OF THE RHEUMATIC DISEASES

Treating the skin with biologics in patients with psoriasis decreases the incidence of psoriatic arthritis

(2021) Maria Laura Acosta Felquer et al.   ANNALS OF THE RHEUMATIC DISEASES

Psoriatic arthritis

(2021) Oliver FitzGerald et al.   Nature Reviews Disease Primers

All‐Cause and Cause‐Specific Mortality in Psoriatic Arthritis and Ankylosing Spondylitis: A Systematic Review and Meta‐Analysis

(2021) Haseeb Chaudhary et al.   ARTHRITIS CARE & RESEARCH

2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases

(2020) Lisa R. Sammaritano et al.   Arthritis & Rheumatology

GO-DACT: a phase 3b randomised, double-blind, placebo-controlled trial of GOlimumab plus methotrexate (MTX) versus placebo plus MTX in improving DACTylitis in MTX-naive patients with psoriatic arthritis

(2020) Elsa Vieira-Sousa et al.   ANNALS OF THE RHEUMATIC DISEASES

Guselkumab in biologic-naive patients with active psoriatic arthritis (DISCOVER-2): a double-blind, randomised, placebo-controlled phase 3 trial

(2020) Philip J Mease et al.   LANCET

Secukinumab versus adalimumab for treatment of active psoriatic arthritis (EXCEED): a double-blind, parallel-group, randomised, active-controlled, phase 3b trial

(2020) Iain B McInnes et al.   LANCET

Secukinumab in patients with psoriatic arthritis and axial manifestations: results from the double-blind, randomised, phase 3 MAXIMISE trial

(2020) Xenofon Baraliakos et al.   ANNALS OF THE RHEUMATIC DISEASES

Upadacitinib for psoriatic arthritis refractory to biologics: SELECT-PsA 2

(2020) Philip J Mease et al.   ANNALS OF THE RHEUMATIC DISEASES

Etanercept and Methotrexate as Monotherapy or in Combination for Psoriatic Arthritis: Primary Results From a Randomized, Controlled Phase 3 Trial

(2019) Philip J. Mease et al.   Arthritis & Rheumatology

Preventing psoriatic arthritis: focusing on patients with psoriasis at increased risk of transition

(2019) Jose U. Scher et al.   Nature Reviews Rheumatology

Achieving remission in psoriatic arthritis by early initiation of TNF inhibition: a double-blind, randomised, placebo-controlled trial of golimumab plus methotrexate versus placebo plus methotrexate

(2019) Leonieke J J van Mens et al.   ANNALS OF THE RHEUMATIC DISEASES

A head-to-head comparison of the efficacy and safety of ixekizumab and adalimumab in biological-naïve patients with active psoriatic arthritis: 24-week results of a randomised, open-label, blinded-assessor trial

(2019) Philip J Mease et al.   ANNALS OF THE RHEUMATIC DISEASES

Bedside to bench: defining the immunopathogenesis of psoriatic arthritis

(2019) Arlene Bravo et al.   Nature Reviews Rheumatology

Efficacy and safety of upadacitinib in patients with active ankylosing spondylitis (SELECT-AXIS 1): a multicentre, randomised, double-blind, placebo-controlled, phase 2/3 trial

(2019) Désirée van der Heijde et al.   LANCET

Effects of ustekinumab versus tumor necrosis factor inhibition on enthesitis: Results from the enthesial clearance in psoriatic arthritis (ECLIPSA) study

(2018) Elizabeth G. Araujo et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Three Multicenter, Randomized, Double-Blind, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Ustekinumab in Axial Spondyloarthritis

(2018) Atul Deodhar et al.   Arthritis & Rheumatology

Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active ankylosing spondylitis (TORTUGA): results from a randomised, placebo-controlled, phase 2 trial

(2018) Désirée van der Heijde et al.   LANCET

Peripheral arthritis in patients with long-term inflammatory bowel disease. Results from 20 years of follow-up in the IBSEN study

(2018) Alvilde Maria Ossum et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

A Multicenter Nominal Group Study to Rank Outcomes Important to Patients, and Their Representation in Existing Composite Outcome Measures for Psoriatic Arthritis

(2017) William Tillett et al.   JOURNAL OF RHEUMATOLOGY

Defining Outcome Measures for Psoriatic Arthritis: A Report from the GRAPPA-OMERACT Working Group

(2017) Alexis Ogdie et al.   JOURNAL OF RHEUMATOLOGY

Efficacy of Subcutaneous Secukinumab in Patients with Active Psoriatic Arthritis Stratified by Prior Tumor Necrosis Factor Inhibitor Use: Results from the Randomized Placebo-controlled FUTURE 2 Study

(2016) A. Kavanaugh et al.   JOURNAL OF RHEUMATOLOGY

Gender differences among patients with primary ankylosing spondylitis and spondylitis associated with psoriasis and inflammatory bowel disease in an iberoamerican spondyloarthritis cohort

(2016) Margarita Landi et al.   MEDICINE

Psoriasis and Psoriatic Arthritis-Related Uveitis: Different Ophthalmological Manifestations and Ocular Inflammation Features

(2016) Alessandro Abbouda et al.   Seminars in Ophthalmology

Methotrexate Efficacy in the Tight Control in Psoriatic Arthritis Study

(2015) Laura C. Coates et al.   JOURNAL OF RHEUMATOLOGY

Effect of tight control of inflammation in early psoriatic arthritis (TICOPA): a UK multicentre, open-label, randomised controlled trial

(2015) Laura C Coates et al.   LANCET

Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic Arthritis

(2015) Philip J. Mease et al.   NEW ENGLAND JOURNAL OF MEDICINE

Clinical features and types of articular involvement in patients with psoriatic arthritis

(2014) Salim Dönmez et al.   CLINICAL RHEUMATOLOGY

Epidemiology and Potential Pathomechanisms of Cardiovascular Comorbidities in Psoriasis: A Report from the GRAPPA 2010 Annual Meeting

(2012) W.-H. BOEHNCKE   JOURNAL OF RHEUMATOLOGY

Treatment recommendations for psoriatic arthritis

(2008) C T Ritchlin et al.   ANNALS OF THE RHEUMATIC DISEASES

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

(2008) Gordon H Guyatt et al.   BMJ-British Medical Journal